Status:
UNKNOWN
Effect of Integrated Care Involving Peripheral Functional Magnetic Stimulation for Sarcopenia
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Sarcopenia
Eligibility:
All Genders
65-90 years
Phase:
NA
Brief Summary
The goal of this clinical randomized trial is to test whether an integrated care involving peripheral functional magnetic stimulation and nutritional supplement is beneficial in population with age-re...
Detailed Description
We will recruit participants with sarcopenia or possible sarcopenia. The participants will be divided into 2 groups. One group, the "integrated care" group, will receive both the peripheral functional...
Eligibility Criteria
Inclusion
- Age from 65 to 90
- Can walk independently for over 15 minutes
- Diagnosed with possible sarcopenia or sarcopenia (by Asian Working Group for Sarcopenia: 2019 Consensus Update onSarcopenia Diagnosis and Treatment)
Exclusion
- Cognitive impairment
- History of cerebrovascular disease
- Deep vein thrombosis
- Malignancy under treatment
- Coagulopathy
- Serious orthopedic condition over limbs
- Inability to walk independently without assistive device
- Any other conditions not suggested to performance exercise
- Medical implants (e.g. pacemaker, defibrillator, deep brain nerve stimulation, infusion pump, etc.)
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06182020
Start Date
December 1 2023
End Date
March 1 2025
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Bei-Hu Branch
Taipei, Taiwan